Tianzhou Yu

Predicting panel attrition in longitudinal HRQoL surveys during the COVID-19 pandemic in the US

Tianzhou Yu, Jiafan Chen, Ning Yan Gu et al. · Health and Quality of Life Outcomes · 2022 · 29 citations · Full text

Trends and disparities in the utilization of influenza vaccines among commercially insured US adults during the COVID-19 pandemic

Kun Li, Tianzhou Yu, Seth A. Seabury et al. · Vaccine · 2022 · 26 citations · Full text

Vaccination, Insured Us Adults, Preventive Medicine +11

Cost-effectiveness of nirsevimab and palivizumab for respiratory syncytial virus prophylaxis in preterm infants 29–34 6/7 weeks' gestation in the United States

Tianzhou Yu, William V. Padula, Leah Yieh et al. · Pediatrics & Neonatology · 2023 · 20 citations · Full text

Vaccination, Preterm Infants 29–34, Respiratory Virus Immunity +8

Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma

Jee H. Choe, Tianzhou Yu, Jeremy S. Abramson et al. · Blood Advances · 2023 · 16 citations · Full text

Cell Therapy, Surgical Oncology, Second-line Lisocabtagene Maraleucel +17

Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans

Tianzhou Yu, Shihan Jin, Chang Li et al. · BioDrugs · 2023 · 10 citations · Full text